kidneys

Views & Analysis

A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company Ardelyx.

News

With $81.3 million raised, Vogenx is the latest in a staggering summer of biotech IPOs. But the queue past this point looks thin.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.